-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617.O1.6 617. Acute Myeloid Leukemias: Commercially Available Therapies: Optimizing Regimens in Children/Young Adults and Around the World

Symposia: Acute Myeloid Leukemias: Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Acute Myeloid Malignancies, AML, Research, Clinical trials, Combination therapy, Adult, Clinical Research, Pediatric, Diseases, Treatment Considerations, Adverse Events, Myeloid Malignancies, Biological Processes, Study Population, Human, Measurable Residual Disease
Monday, December 9, 2024: 4:30 PM-6:00 PM
Grand Hall B (Manchester Grand Hyatt San Diego)
Moderators:
Farhad Ravandi, MBBS, University of Texas- MD Anderson Cancer Center and Christine M. McMahon, MD, University of Colorado School of Medicine
Disclosures:
Ravandi: Prelude: Consultancy, Honoraria, Research Funding; Astellas: Consultancy, Honoraria; Abbvie: Consultancy, Honoraria; Xencor: Research Funding; Amgen: Research Funding; Syros: Consultancy, Honoraria, Research Funding; BMS: Consultancy, Honoraria; Astyex/Taiho: Research Funding; Syndax: Honoraria.
4:30 PM

Jessica A. Pollard, MD1, Todd A. Alonzo, PhD2*, Robert Gerbing, MS3*, Matthew A. Kutny, MD4, Betsy Hirsch, PhD5*, Gordana Raca, MD, PhD6, Kasey Leger, MD, MSc7, Jennifer J. Wilkes, MD, MSCE8, Aman Wadhwa, MD9, Zachary Graff, MD10, Reena Pabari, MD, MSc, FRCPC11*, Samir Kahwash, MD12*, Karen M Chisholm, MD, PhD13, Joseph Chewning, MD14, John T. Horan, MD15, Richard Aplenc16, Katherine Tarlock, MD17, Sarah Menig, PharmD, BCOP18*, Olga Militano, PharmD19*, Bonnie Ky, MD20*, Chad A. Hudson, MD, PhD21, Lisa Eidenschink Brodersen, PhD16*, Michael R. Loken, PhD21*, Soheil Meshinchi, MD, PhD22, Anders Kolb, MD23 and Todd M Cooper, DO24

1Dana Farber Cancer Institute and Boston Children’s Hospital, Boston, MA
2Univ. of Southern California Keck School of Med., Monrovia, CA
3Children's Oncology Group, Arcadia, CA
4University of Alabama Birmingham, Birmingham, AL
5University of Minnesota, Minneapolis, MN
6Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA
7Seattle Children’s Hospital, Seattle, WA
8Pediatrics, University of Washington School of Medicine, Seattle, WA
9Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
10Medical College of Wisconsin, Milwaukee, WI
11The Hospital for Sick Children, Toronto, ON, Canada
12Nationwide Children's Hospital, The Ohio State University, Columbus, OH
13University of Washington, Seattle, WA
14Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL
15University of Rochester Medical Center, Rochestser
16Children's Hospital of Philadelphia, Philadelphia, PA
17Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
18Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA
19Children's Oncology Group, Monrovia, CA
20University of Pennsylvania School of Medicine, Philadelphia, PA
21Hematologics, Inc., Seattle, WA
22Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
23Leukemia & Lymphoma Society, Bronx, NY
24Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Childrens Hospital, Seattle, WA

4:45 PM

Brenda Gibson, MD1*, André Baruchel, MD, PhD2, Andrew Moore, MBBS, PhD, FRACP3*, Shanna Maycock, MSc4*, Owen Smith, MD5*, Geoff Shenton6*, Jean-Pierre Bourquin, MD, PhD7, Yves Bertrand, MD8*, Nicholas Heaney1*, Anna Lawson, BSc9*, Persis Jal Amrolia10*, Gerard Michel, MD, PhD11*, Jean-Hugues Dalle, MD, PHD12, Marc Ansari, MD, PhD13, Hélène Lapillonne, MD, PhD14*, Richard Dillon, MA15, Jelena Jovanovic, PhD16*, Siobhan Cross, MD17*, Paul Virgo18*, Lucy Wheeler19*, Christophe Roumier, PharmD20*, Nicolas Duployez, PharmD, PhD21*, Christine Harrison, PhD, FRCPath22*, Claire Schwab, PhD22*, Wendy Cuccuini, MD, PhD23*, Marina Lafage-Pochitaloff, MD, PhD24*, Claude Preudhomme, PharmD, PhD25*, Paresh Vyas, FMedSci, DPhil, FRCPath26*, Pierre Hirsch, MD, PhD27*, Gareth Veal, PhD22*, David Gillis, MBBS, FRACP, FRCPA28*, Pam Kearns, MBChB, PhD, FRCPC9*, Guy Leverger, MD, PhD29*, Phil Ancliff30*, Aimee Jackson, BSc MSc31* and Arnaud Petit, MD, PhD32*

1Royal Hospital for Children, Glasgow, Glasgow, United Kingdom
2Hôpital Universitaire Robert Debré (APHP and Université Paris Cité), Paris, France
3Child Health Research Centre, The University of Queensland, South Brisbane, QLD, Australia
4Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, United Kingdom
5Children's Health Ireland, Dublin, Ireland
6Great North Children’s Hospital, Newcastle, United Kingdom
7Department of Pediatric Oncology, University Children's Hospital Zurich, Zurich, Switzerland
8Pediatric Hematology, Institut d'Hématologie et Oncologie Pédiatrique, Lyon, France
9Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom
10Bone Marrow Transplant Department, Great Ormond Street Hospital, London, United Kingdom
11CHU de Marseille Hôpital de la Timone Enfants, Marseille, France
12Department of Pediatric Hematology and Immunology, Robert-Debré Academic Hospital ,, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
13Department of Pediatrics, Onco-Hematology Unit,, Geneva University Hospital, Geneva, Switzerland
14Laboratory of Hematology and Flow cytometry, Trousseau Hospital, Paris, France
15Guy's and St. Thomas' NHS Foundation Trust, London, ENG, United Kingdom
16King’s College London, London, United Kingdom
17Christchurch Hospital, Christchurch, NZL
18Southmead Hospital, Bristol, GBR
19Southmead Hospital, North Bristol NHS Trust, Bristol, United Kingdom
20ONCOLILLE - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France
21Laboratory of Hematology-Molecular Biology, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France
22Newcastle University, Newcastle, United Kingdom
23Saint Louis Hospital, Paris, France
24CHU Timone Enfants, Marseille, France
25Laboratory of Hematology-Molecular Biology, CHU Lille, Lille, France
26Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
27Hematology Laboratory, Saint Antoine University Hospital, AP-HP, Paris, France
28Royal Brisbane and Women's Hospital, Brisbane, Australia
29Pediatric Hematology Oncology Immunology Department, Hôpital Trousseau, Paris, France
30Department of Haematology, Great Ormond Street Hospital for Children, London, United Kingdom
31Cancer Research UK Trials Unit, University of Birmingham, Birmingham, United Kingdom
32Hôpital Armand Trousseau, APHP, PARIS, Île-de-France, France

5:00 PM

Justin M. Watts, MD1, Connor Sohalski2*, Alessia Zoso, PhD3*, Jessica Dell-Martin4*, Ayele Belachew5*, Diana Abbott, PhD6, Maria L Amaya, MD, PhD2,7, Andrew Kent, MD, PhD5, Christine M. McMahon, MD8, Marc Schwartz, MD5,9, Mikkael A. Sekeres, MD10,11, Clayton Smith, MD12, Sangeetha Venugopal, MD, MS11, Craig T Jordan, PhD13, Mary Berg, MD14*, Mary Haag15*, Nicholas Willard16*, Dara Aisner2*, Jeffrey Schowinsky2*, Zenggang Pan, MD, PhD17*, Jingjing Zhang2*, Jonathan Gutman, MD5 and Daniel A Pollyea, MD9

1Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL
2University of Colorado, Aurora, CO
3University of Miami Sylvester Cancer Center, Miami, FL
4University of Colorado Anschutz Medical Campus, Aurora, CO
5Division of Hematology, University of Colorado, Aurora, CO
6Center for Innovative Design and Analysis (CIDA), Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado, Anschutz Medical Campus, Aurora, CO
7Rocky Mountain Regional VA Medical Center, Aurora, CO
8University of Colorado School of Medicine, Denver, CO
9Division of Hematology, University of Colorado, Denver, CO
10Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
11Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
12CU Innovations, University of Colorado, Aurora, CO
13Division of Hematology, University of Colorado Anschutz Medical Campus, Aurora, CO
14University of Colorado Program, Aurora, CO
15University of Colorado, Aurora
16University of Colorado Children's Hospital, Aurora
17Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO

5:15 PM

Agnieszka Wierzbowska1,2, Agnieszka Pluta1,2*, Anna Czyz3*, Marta Libura4*, Sebastian Giebel, MD, PhD5*, Michał Soin1*, Damian Mikulski6,7*, Kacper Kościelny6*, Wojciech Fendler6*, Magdalena Czemerska1,2*, Agata Majchrzak2*, Anna Kopinska8*, Krzysztof Woźniczka8*, Martyna Włodarczyk1*, Karol Wójcik9*, Grzegorz Helbig8*, Małgorzata Raźny9*, Marta Sobas, MD10*, Tomasz Wróbel, MD, PhD10*, Donata Szymczak10*, Andrzej Szczepaniak, MD11*, Lidia Gil, MD, PhD12, Magdalena Dutka13*, Maria Bieniaszewska14*, Tomasz Gromek15*, Marek Hus, MD, PhD16*, Edyta Cichocka17*, Janusz Hałka18*, Elzbieta Patkowska19*, Marzena Wątek19*, Jolanta Wozniak19*, Ewa Lech-Maranda, MD, PhD19*, Agata Obara20*, Agnieszka Kopacz21*, Katarzyna Dulik5*, Grzegorz Charlinski17*, Jerzy Holowiecki5*, Andi Rustani22*, Ameenah Sukkur22*, Nuria Mencia-Trinchant22*, Pinkal Desai23, Michael Samuel22*, Justin D. Kaner, MD24, Michal Bar-Natan, MD22, Jonathan Canaani, MD25, Ellen K. Ritchie, MD22, Monica L Guzman, PhD22, Sylvie D Freeman26 and Gail J. Roboz, MD22

1Department of Hematology, Medical University of Lodz, Lodz, Poland
2Department of Hematology and Transplantology, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland
3Deaprtment of Hematology, Medical University of Wroclaw, Wroclaw, Poland
4Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Warsaw, Poland
5Department of Hematology and Bone Marrow Transplantation, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland
6Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland
7Department of Hematooncology, Multidisciplinary Provincial Centre of Traumatology and Oncology Nicolas Copernicus in Lodz, Lodz, Poland
8Department of Hematology, Medical University of Silesia, Katowice, Poland
9Department of Hematology, Municipial Specialist Hospital, Cracow, Poland
10Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Medical University of Wroclaw, Wroclaw, Poland
11Department of Hematology and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poznan, Poland
12Department of Hematology, Medical University of Poznań, Poznan, Poland
13Department of Hematology and Transplantology, Medical University of Gdansk and University Clinical Center in Gdansk, Gdansk, Poland
14Department of Hematology, Medical University of Gdańsk, Gdansk, Poland
15Department of Hematology, Medical University of Lublin, Lublin, Poland
16Medical University of Lublin, Lublin, Poland
17Department of Hematology, Nicolaus Copernicus Municipal Specialist Hospital, Torun, Poland
18Department of Hematology, Municipal Specialist Hospital, Olsztyn, Poland
19Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
20Department of Hematology, Holly Cross Oncology Center, Kielce, Poland
21Department of Hematology, Voivodeship Specialistic Hospital in Rzeszów, Rzeszow, Poland
22Weill Cornell Medicine and The New York Presbyterian Hospital in New York City, New York, NY
23Weill Cornell Medicine New York Presbyterian Hospital, New York, NY
24New York-Presbyterian/Weill Cornell Medical Center, New York, NY
25Weill Cornell Medicine and The New York Presbyterian Hospital in New York City, Brooklyn, NY
26Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

5:30 PM

Jing Lu, MD1*, Shengli Xue1*, Ying Wang1*, Xuefeng He, MD, PhD2,3*, Xiaohui Hu1*, Miao Miao, MD1*, Yang Zhang4*, Zaixiang Tang5*, Jundan Xie1*, Xiaofei Yang1*, Mingzhu Xu1*, Yaoyao Shen1*, Feng Du2*, Qian Vicky Wu1*, Mengxing Xue1*, Yun Wang1*, Ailing Deng1*, Xueqing Dou1*, Haiping Dai1*, Depei Wu, MD, PhD6 and Suning Chen, MD, PhD1*

1The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
2Soochow Hopes Hematonosis Hospital, Suzhou, China
3Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
4Canglang Hospital of Suzhou, Suzhou, China
5Department of Biostatistics, Soochow University, Suzhou, CHN
6Department of Hematology, The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China

5:45 PM

Zinan Feng*, Yu Zhang, MD*, Hui Liu*, Sijian Yu*, Qifa Liu, MD and Li Xuan*

Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China

*signifies non-member of ASH